Press Releases | NeoGenomics Laboratories

As of November 1, 2020, we will discontinue future development for Internet Explorer

To have a better experience, please upgrade to Microsoft Edge, Google Chrome, or Firefox. Sorry for the convenience.

Presented: November 9, 2020

NeoGenomics to Offer Mobile Phlebotomy Services for Liquid Biopsy Tests

Presented: October 27, 2020

NeoGenomics Reports Revenue Growth of 20% to Record $125 Million in the Third Quarter

Presented: October 13, 2020

NeoGenomics Announces Plans to Expand Global Footprint in Pharma Services by Opening Clinical Research Laboratory in Suzhou, China

Presented: October 1, 2020

NeoGenomics Schedules Its Third Quarter Earnings Release for October 27, 2020

Presented: July 28, 2020

NeoGenomics Reports Revenue of $87 Million in the Second Quarter amid COVID-19 Pandemic

Presented: July 20, 2020

NeoGenomics Announces Board Appointments

Presented: July 1, 2020

NeoGenomics Schedules its Second Quarter Earnings Release for July 28, 2020

Presented: June 29, 2020

NeoGenomics To Virtually Present At The Raymond James Human Health Innovation Conference

Presented: June 29, 2020

NeoGenomics Launches Comprehensive Suite of Solid Tumor Liquid Biopsy Tests for Cancer Patients

Presented: June 2, 2020

NeoGenomics To Virtually Present At The Raymond James Human Health Innovation Conference

Presented: June 1, 2020

NeoGenomics To Virtually Participate In Fireside Chat At The 40th Annual William Blair Growth Stock Conference